Soy Protein Recovery Randomized Trial Evidence Table

Structured evidence table for Soy Protein Recovery Randomized Trial, generated from 2 reusable source documents in the Migaku knowledge base.

topicclaimevidence levelcitationsource
Soy Protein Recovery Randomized Trial1 Aging is characterized by progressive physiological decline, including loss of skeletal muscle mass and function (Sarcopenia), reduced mitochondrial efficiency, and increased oxidative stress, all of which contribute to frailty and diminished quality of life in older adults ().3Wang Xiaolan (2026)Glycine and N-acetylcysteine supplementation, with or without exercise, in brain health and functional aging: implications for sarcopenia and frailty in older adults
Soy Protein Recovery Randomized Trial1 2 3 4 5 By the age of 70, individuals may experience a 25%−30% reduction in muscle mass, which is strongly associated with impaired mobility, falls, and loss of independence ().3Wang Xiaolan (2026)Glycine and N-acetylcysteine supplementation, with or without exercise, in brain health and functional aging: implications for sarcopenia and frailty in older adults
Soy Protein Recovery Randomized TrialLow circulating glycine levels have been associated with insulin resistance, obesity, and higher cardiometabolic risk (,).3Wang Xiaolan (2026)Glycine and N-acetylcysteine supplementation, with or without exercise, in brain health and functional aging: implications for sarcopenia and frailty in older adults
Soy Protein Recovery Randomized TrialIn this review, the term “older adults” generally refers to individuals aged ≥60 or ≥65 years, consistent with definitions used by the World Health Organization and most geriatric clinical trials.3Wang Xiaolan (2026)Glycine and N-acetylcysteine supplementation, with or without exercise, in brain health and functional aging: implications for sarcopenia and frailty in older adults
Soy Protein Recovery Randomized TrialOur understanding of the metabolic response to critical illness continues to evolve and delivery of nutrition therapy in the intensive care unit (ICU) has become more nuanced.4Yeh DD (2026)Fueling recovery: evidence-based ICU nutrition and immunonutrition strategies in 2026.
Soy Protein Recovery Randomized TrialBoth underfeeding and overfeeding have recognized harms, and it is often challenging to provide the right dose at the right time by the right route to the right patient.4Yeh DD (2026)Fueling recovery: evidence-based ICU nutrition and immunonutrition strategies in 2026.
topicSoy Protein Recovery Randomized Trial
claim1 Aging is characterized by progressive physiological decline, including loss of skeletal muscle mass and function (Sarcopenia), reduced mitochondrial efficiency, and increased oxidative stress, all of which contribute to frailty and diminished quality of life in older adults ().
evidence level3
citationWang Xiaolan (2026)
sourceGlycine and N-acetylcysteine supplementation, with or without exercise, in brain health and functional aging: implications for sarcopenia and frailty in older adults
topicSoy Protein Recovery Randomized Trial
claim1 2 3 4 5 By the age of 70, individuals may experience a 25%−30% reduction in muscle mass, which is strongly associated with impaired mobility, falls, and loss of independence ().
evidence level3
citationWang Xiaolan (2026)
sourceGlycine and N-acetylcysteine supplementation, with or without exercise, in brain health and functional aging: implications for sarcopenia and frailty in older adults
topicSoy Protein Recovery Randomized Trial
claimLow circulating glycine levels have been associated with insulin resistance, obesity, and higher cardiometabolic risk (,).
evidence level3
citationWang Xiaolan (2026)
sourceGlycine and N-acetylcysteine supplementation, with or without exercise, in brain health and functional aging: implications for sarcopenia and frailty in older adults
topicSoy Protein Recovery Randomized Trial
claimIn this review, the term “older adults” generally refers to individuals aged ≥60 or ≥65 years, consistent with definitions used by the World Health Organization and most geriatric clinical trials.
evidence level3
citationWang Xiaolan (2026)
sourceGlycine and N-acetylcysteine supplementation, with or without exercise, in brain health and functional aging: implications for sarcopenia and frailty in older adults
topicSoy Protein Recovery Randomized Trial
claimOur understanding of the metabolic response to critical illness continues to evolve and delivery of nutrition therapy in the intensive care unit (ICU) has become more nuanced.
evidence level4
citationYeh DD (2026)
sourceFueling recovery: evidence-based ICU nutrition and immunonutrition strategies in 2026.
topicSoy Protein Recovery Randomized Trial
claimBoth underfeeding and overfeeding have recognized harms, and it is often challenging to provide the right dose at the right time by the right route to the right patient.
evidence level4
citationYeh DD (2026)
sourceFueling recovery: evidence-based ICU nutrition and immunonutrition strategies in 2026.

Source documents

  1. Glycine and N-acetylcysteine supplementation, with or without exercise, in brain health and functional aging: implications for sarcopenia and frailty in older adults
  2. Fueling recovery: evidence-based ICU nutrition and immunonutrition strategies in 2026.